Corbus Pharmaceuticals Holding (CRBP NASDAQ) stock market data APIs
$9.4056
0.07(0.7%)
as of September 12, 2025
Try our APIs with
free plan!
Corbus Pharmaceuticals Holding Financial Data Overview
Price chart is built with
Anychart
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Prev. Close
9.4056
Open
9.4723
High
9.5734
Low
9.2586
52 wk Range
4.64-55.688
Market Cap
116 M
Shares Outstanding
12 255 K
EPS
-1.44
Beta
3.092
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Corbus Pharmaceuticals Holding (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Corbus Pharmaceuticals Holding data using free add-ons & libraries
Get Corbus Pharmaceuticals Holding Fundamental Data
Corbus Pharmaceuticals Holding Fundamental data includes:
- Net Revenue:
- EBITDA: -66 617 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-05
- EPS/Forecast: -1.23
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Corbus Pharmaceuticals Holding News
New
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
When Canada legalized recreational cannabis in 2018, many believed that the United States wouldn’t be far behind. Optimism grew further when the 2018 Farm Bill legalized hemp nationwide, fueling hop...
Corbus Pharma's Q2 Net Loss Widens
(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a U.S.-based pharmaceutical company, reported a wider loss in the second quarter. The company reported a net loss of $17.7 million or $1.44 p...
Corbus Pharmaceuticals GAAP EPS of -$1.44 misses by $0.08
* Corbus Pharmaceuticals press release [https://seekingalpha.com/pr/20188901-corbus-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides-a-corporate] (NASDAQ:CRBP [https://seek...
Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
Combination cohort initiated following successful review of monotherapy cohortOver 100 participants dosed to-date in monotherapy cohortPriority are Head and Neck Squamous Cell Carcinoma (HNSCC) and ce...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
